Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19

Faruque Pathan,1 Shahjada Selim,2 Md Fariduddin,2 Md Hafizur Rahman,3 SM Ashrafuzzaman,1 Faria Afsana,1 Nazmul Kabir Qureshi,4 Tanjina Hossain,5 M Saifuddin,6 AB Kamrul-Hasan,7 Ahmed Salam Mir8 On behalf of the BES Diabetes and COVID Task Force1Department of Endocrinology, BIRDEM General Hospital, D...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pathan F, Selim S, Fariduddin M, Rahman MH, Ashrafuzzaman SM, Afsana F, Qureshi NK, Hossain T, Saifuddin M, Kamrul-Hasan AB, Mir AS
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	covid-19 diabetes mellitus sars cov-2 antidiabetic medications endocrine diseases and covid-19 thyroid disease and covid-19 Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/c2877f5bce11418a913927b1b048f2a6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19

Ejemplares similares